Overview

Detailed Summary

Chemfab Alkalis Limited manufactures caustic soda and related chlor‑alkali products from a 65,700 TPA plant and has a high‑growth OPVC pipes business producing up to 630mm diameter pipes, with manufacturing units in Puducherry and Sri City and a ~59:41 revenue mix favouring chlor‑alkali in FY25.
The company is actively modernising its chlor‑alkali operations with a ₹60 crore technology upgrade completed in December 2025 and a ₹15 crore hybrid power investment expected to deliver significant annual cost savings once ISTS transmission clearances enable power supply from Q4FY26.
Chemfab has rapidly scaled OPVC production through a plug‑and‑play model with Molecor technology, expanding from 3,000 TPA in 2018 to a planned 23,000 TPA in FY26; each new line has an estimated ₹45–50 crore revenue potential and a 2–2.5 year payback period.
Recent quarter results show a trough in consolidated performance with Q3FY26 consolidated revenue of ₹62.17 crore and operational EBITDA of ₹5.17 crore; OPVC margins compressed sequentially due to slow Jal Jeevan Mission fund flows, while chlor‑alkali ECU realisations show signs of stabilising around ₹38,500/MT.

Sector: Chemicals & Petrochemicals
Industry: Commodity Chemicals
Market Cap: 586 Cr
Volatility: Moderate Risk
P/E Ratio: -170.7
Industry P/E: 42.6
PEG Ratio: —
P/B Ratio: 1.6
52W High: 845.65
52W Low: 270.00

Sales CAGR

1Y: 2.16%
3Y: 5.85%
5Y: 9.51%
10Y: 31.24%

Profit CAGR

1Y: -126.37%
3Y: -19.18%
5Y: -9.86%
10Y: 48.20%

ROE

TTM: -0.91%
3Y: 9.57%
5Y: 7.64%
10Y: 8.15%

ROCE

TTM: 1.49%
3Y: 12.83%
5Y: 11.12%
10Y: 11.34%

Technicals

‌

Forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
TUTICORALK		55.38	668 Cr	18.26	3.70	0.00	20.25	13.95	5.90
VIKRAMTH		206.00	643 Cr	16.70	4.10	0.61	24.54	32.63	20.49
PRIMO		26.36	639 Cr	41.59	1.72	0.00	3.78	6.57	1.52
CHEMFAB		409.00	588 Cr	-171.39	1.57	0.31	-0.91	1.49	-0.59
OCCLLTD		114.15	574 Cr	12.04	1.33	1.57	11.06	11.62	7.93
TRANSPEK		996.25	556 Cr	12.19	0.73	2.01	5.95	8.23	4.53
POEL		165.05	508 Cr	12.24	2.61	0.48	21.32	21.36	10.86
Median: 7 Co.	—	165.05	588 Cr	12.24	1.72	0.48	11.06	11.62	5.90

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	86	82	77	82	84	92	92	77	68	75
Expenses	71	70	68	72	72	79	80	71	66	66
Operating Profit	15	12	8.33	10	12	13	11	5.46	1.94	8.52
OPM %	17.61	14.97	10.88	12.39	14.24	14.44	12.34	7.13	2.85	11.39
Other Income	1.51	1.90	2.59	0.60	2.55	-8.51	1.36	1.76	2.77	2.80
Interest	0.43	0.41	0.94	1.22	1.20	1.57	1.57	1.94	2.03	2.14
Depreciation	5.45	5.86	7.31	8.80	9.62	11	6.39	6.61	7.47	7.95
Profit Before Tax	11	7.96	2.67	0.73	3.64	-7.35	4.70	-1.33	-4.79	1.23
Tax %	34.35	32.04	66.67	172.60	48.35	-25.03	45.74	-51.13	7.31	60.16
Net Profit	7.10	5.41	0.90	-0.53	1.88	-9.19	2.55	-2.01	-4.45	0.48
EPS in Rs	4.90	3.72	0.61	-0.37	1.30	-6.38	1.77	-1.40	-3.09	0.34

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	205	181	272	331	327	334	349
Expenses	149	158	215	221	273	291	303
Operating Profit	55	23	57	110	54	44	47
OPM %	26.91	12.88	20.85	33.34	16.47	13.08	13.36
Other Income	-0.10	1.42	5.70	2.15	8.54	-2.77	-4.00
Interest	3.15	2.45	1.01	0.24	0.94	4.93	5.56
Depreciation	25	20	22	23	22	36	35
Profit Before Tax	27	2.03	39	89	39	-0.31	1.72
Tax %	4.74	501.40	26.48	27.79	32.76	-2,172.53	407.56
Net Profit	25	-8.13	29	65	26	-6.94	-5.29
EPS in Rs	—	-5.67	19.83	44.45	18.13	-4.83	-2.38
Dividend Payout %	6.88	0.00	6.19	2.77	6.82	-25.83	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	14	14	14	14	14	14
Reserves	262	253	284	347	373	366
Borrowings	37	32	8.65	2.36	20	84
Other Liabilities	36	36	46	48	93	57
Total Liabilities	348	335	352	412	500	522
Fixed Assets	195	202	194	192	247	317
CWIP	35	3.40	8.19	31	74	36
Investments	0.69	24	31	68	5.48	16
Other Assets	118	105	119	121	174	152
Total Assets	348	335	352	412	500	522

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	54	45	55	93	31	40
Cash from Investing Activity	-58	-6.43	-21	-48	-110	-86
Cash from Financing Activity	2.91	-16	-25	-8.89	16	59
Net Cash Flow	-1.01	23	9.31	36	-62	13

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	73.11%	72.99%	72.88%	72.88%	72.88%	72.63%	72.57%	72.18%	72.18%	72.18%	72.13%	72.13%
FIIs	0.28%	0.24%	0.29%	0.35%	0.27%	0.11%	0.03%	0.03%	0.02%	0.00%	0.08%	0.04%
DIIs	0.08%	0.08%	0.10%	0.10%	0.08%	0.08%	0.28%	0.27%	0.27%	0.34%	0.28%	0.17%
Public	26.53%	26.70%	26.73%	26.67%	26.77%	27.19%	27.12%	27.51%	27.53%	27.48%	27.50%	27.65%
Total Shareholders	11,098	12,136	11,745	12,624	11,704	12,536	12,430	11,877	11,586	11,586	11,370	10,942

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q1 FY26

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Regulatory Notice

2 days ago

Special window for transfer and dematerialisation of physical shares

Chemfab Alkalis published a newspaper notice under SEBI circular (30 Jan 2026) announcing a special one‑year window (05 Feb 2026–04 Feb 2027) for transfer‑cum‑dematerialisation of physical shares with eligibility matrix and RTA submission instructions.

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Chemfab Alkalis Ltd

Chemfab Alkalis Ltd (CHEMFAB) is currently trading at 407.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Chemfab Alkalis Limited manufactures caustic soda and related chlor‑alkali products from a 65,700 TPA plant and has a high‑growth OPVC pipes business producing up to 630mm diameter pipes, with manufacturing units in Puducherry and Sri City and a ~59:41 revenue mix favouring chlor‑alkali in FY25. The company is actively modernising its chlor‑alkali operations with a ₹60 crore technology upgrade completed in December 2025 and a ₹15 crore hybrid power investment expected to deliver significant annual cost savings once ISTS transmission clearances enable power supply from Q4FY26. Chemfab has rapidly scaled OPVC production through a plug‑and‑play model with Molecor technology, expanding from 3,000 TPA in 2018 to a planned 23,000 TPA in FY26; each new line has an estimated ₹45–50 crore revenue potential and a 2–2.5 year payback period. Recent quarter results show a trough in consolidated performance with Q3FY26 consolidated revenue of ₹62.17 crore and operational EBITDA of ₹5.17 crore; OPVC margins compressed sequentially due to slow Jal Jeevan Mission fund flows, while chlor‑alkali ECU realisations show signs of stabilising around ₹38,500/MT.

Over the past 52 weeks, Chemfab Alkalis Ltd has traded between a low of ₹270.00 and a high of ₹845.65. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Chemfab Alkalis Ltd has a market capitalization of approximately 585.51. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Chemfab Alkalis Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -170.70 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 585.51 Cr, Chemfab Alkalis Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Chemfab Alkalis Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Chemfab Alkalis Ltd is -170.70. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Chemfab Alkalis Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison